A detailed history of Aster Capital Management (Difc) LTD transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 21,601 shares of ABEO stock, worth $123,125. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,601
Holding current value
$123,125
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.12 - $6.32 $88,996 - $136,518
21,601 New
21,601 $137 Million

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $33.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Aster Capital Management (Difc) LTD Portfolio

Follow Aster Capital Management (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aster Capital Management (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aster Capital Management (Difc) LTD with notifications on news.